Literature DB >> 20678469

Phosphoinositide 3-kinase-gamma expression is upregulated in brain microglia and contributes to ischemia-induced microglial activation in acute experimental stroke.

Rong Jin1, Shiyong Yu, Zifang Song, Joseph W Quillin, Daniel P Deasis, Josef M Penninger, Anil Nanda, D Neil Granger, Guohong Li.   

Abstract

Microglia, the resident microphages of the CNS, are rapidly activated after ischemic stroke. Inhibition of microglial activation may protect the brain by attenuating blood-brain barrier damage and neuronal apoptosis after ischemic stroke. However, the mechanisms by which microglia is activated following cerebral ischemia is not well defined. In this study, we investigated the expression of PI3Kgamma in normal and ischemic brains and found that PI3Kgamma mRNA and protein are constitutively expressed in normal brain microvessels, but significantly upregulated in postischemic brain primarily in activated microglia following cerebral ischemia. In vitro, the expression of PI3Kgamma mRNA and protein was verified in mouse brain endothelial and microglial cell lines. Importantly, absence of PI3Kgamma blocked the early microglia activation (at 4h) and subsequent expansion (at 24-72 h) in PI3Kgamma knockout mice. The results suggest that PI3Kgamma is an ischemia-responsive gene in brain microglia and contributes to ischemia-induced microglial activation and expansion. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20678469      PMCID: PMC3169085          DOI: 10.1016/j.bbrc.2010.07.116

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  28 in total

1.  Microglia potentiate damage to blood-brain barrier constituents: improvement by minocycline in vivo and in vitro.

Authors:  Midori A Yenari; Lijun Xu; Xian Nan Tang; Yanli Qiao; Rona G Giffard
Journal:  Stroke       Date:  2006-02-23       Impact factor: 7.914

Review 2.  The role of microglia and macrophages in the pathophysiology of the CNS.

Authors:  G Stoll; S Jander
Journal:  Prog Neurobiol       Date:  1999-06       Impact factor: 11.685

3.  Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis.

Authors:  Montserrat Camps; Thomas Rückle; Hong Ji; Vittoria Ardissone; Felix Rintelen; Jeffrey Shaw; Chiara Ferrandi; Christian Chabert; Corine Gillieron; Bernard Françon; Thierry Martin; Denise Gretener; Dominique Perrin; Didier Leroy; Pierre-Alain Vitte; Emilio Hirsch; Matthias P Wymann; Rocco Cirillo; Matthias K Schwarz; Christian Rommel
Journal:  Nat Med       Date:  2005-08-28       Impact factor: 53.440

4.  PI3Kgamma inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus.

Authors:  Domingo F Barber; Almira Bartolomé; Carmen Hernandez; Juana M Flores; Clara Redondo; Cristina Fernandez-Arias; Montserrat Camps; Thomas Rückle; Matthias K Schwarz; Santiago Rodríguez; Carlos Martinez-A; Dimitrios Balomenos; Christian Rommel; Ana C Carrera
Journal:  Nat Med       Date:  2005-08-28       Impact factor: 53.440

Review 5.  Cerebrovascular angiotensin AT1 receptor regulation in cerebral ischemia.

Authors:  Lars Edvinsson
Journal:  Trends Cardiovasc Med       Date:  2008-04       Impact factor: 6.677

6.  Blood cell-derived RANTES mediates cerebral microvascular dysfunction, inflammation, and tissue injury after focal ischemia-reperfusion.

Authors:  Satoshi Terao; Gokhan Yilmaz; Karen Y Stokes; Janice Russell; Mami Ishikawa; Takeshi Kawase; D Neil Granger
Journal:  Stroke       Date:  2008-07-17       Impact factor: 7.914

7.  Phosphatidylinositol 3-kinase gamma signaling through protein kinase Czeta induces NADPH oxidase-mediated oxidant generation and NF-kappaB activation in endothelial cells.

Authors:  Randall S Frey; Xiaopei Gao; Kamran Javaid; Shahid S Siddiqui; Arshad Rahman; Asrar B Malik
Journal:  J Biol Chem       Date:  2006-03-09       Impact factor: 5.157

8.  Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain.

Authors:  Mélanie Lalancette-Hébert; Geneviève Gowing; Alain Simard; Yuan Cheng Weng; Jasna Kriz
Journal:  J Neurosci       Date:  2007-03-07       Impact factor: 6.167

9.  Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation.

Authors:  E Hirsch; V L Katanaev; C Garlanda; O Azzolino; L Pirola; L Silengo; S Sozzani; A Mantovani; F Altruda; M P Wymann
Journal:  Science       Date:  2000-02-11       Impact factor: 47.728

Review 10.  Fibrin-modifying serine proteases thrombin, tPA, and plasmin in ischemic stroke: a review.

Authors:  John J Sheehan; Stella E Tsirka
Journal:  Glia       Date:  2005-06       Impact factor: 8.073

View more
  16 in total

1.  PI3Kγ (Phosphoinositide 3-Kinase-γ) Inhibition Attenuates Tissue-Type Plasminogen Activator-Induced Brain Hemorrhage and Improves Microvascular Patency After Embolic Stroke.

Authors:  Rong Jin; Adam Y Xiao; Jarvis Li; Min Wang; Guohong Li
Journal:  Hypertension       Date:  2019-01       Impact factor: 10.190

2.  Inhibition of CD147 improves oligodendrogenesis and promotes white matter integrity and functional recovery in mice after ischemic stroke.

Authors:  Shan Liu; Rong Jin; Adam Y Xiao; Wei Zhong; Guohong Li
Journal:  Brain Behav Immun       Date:  2019-07-26       Impact factor: 7.217

3.  The Paradoxical Effects of Chronic Intra-Amniotic Ureaplasma parvum Exposure on Ovine Fetal Brain Development.

Authors:  Ruth Gussenhoven; Daan R M G Ophelders; Matthew W Kemp; Matthew S Payne; Owen B Spiller; Michael L Beeton; Sarah J Stock; Bertha Cillero-Pastor; Florian P Y Barré; Ron M A Heeren; Lilian Kessels; Bas Stevens; Bart P Rutten; Suhas G Kallapur; Alan H Jobe; Boris W Kramer; Tim G A M Wolfs
Journal:  Dev Neurosci       Date:  2017-08-29       Impact factor: 2.984

4.  Induction of Neuronal PI3Kγ Contributes to Endoplasmic Reticulum Stress and Long-Term Functional Impairment in a Murine Model of Traumatic Brain Injury.

Authors:  Shan Liu; Rong Jin; Adam Y Xiao; Rui Chen; Jarvis Li; Wei Zhong; Xiaozhou Feng; Guohong Li
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

Review 5.  PI3K pathway inhibitors: potential prospects as adjuncts to vaccine immunotherapy for glioblastoma.

Authors:  Taemin Oh; Michael E Ivan; Matthew Z Sun; Michael Safaee; Shayan Fakurnejad; Aaron J Clark; Eli T Sayegh; Orin Bloch; Andrew T Parsa
Journal:  Immunotherapy       Date:  2014       Impact factor: 4.196

6.  Early Activation of Phosphatidylinositol 3-Kinase after Ischemic Stroke Reduces Infarct Volume and Improves Long-Term Behavior.

Authors:  Young Seo Kim; Arum Yoo; Jeong Woo Son; Hyun Young Kim; Young-Jun Lee; Sejin Hwang; Kyu-Yong Lee; Young Joo Lee; Cenk Ayata; Hyung-Hwan Kim; Seong-Ho Koh
Journal:  Mol Neurobiol       Date:  2016-09-02       Impact factor: 5.590

7.  Phosphatidylinositol-3-kinase gamma plays a central role in blood-brain barrier dysfunction in acute experimental stroke.

Authors:  Rong Jin; Zifang Song; Shiyong Yu; Abigail Piazza; Anil Nanda; Josef M Penninger; D Neil Granger; Guohong Li
Journal:  Stroke       Date:  2011-05-05       Impact factor: 7.914

8.  Phosphoinositide 3-Kinase Gamma Contributes to Neuroinflammation in a Rat Model of Surgical Brain Injury.

Authors:  Lei Huang; Prativa Sherchan; Yuechun Wang; Cesar Reis; Richard L Applegate; Jiping Tang; John H Zhang
Journal:  J Neurosci       Date:  2015-07-22       Impact factor: 6.167

9.  Inhibition of CD147 (Cluster of Differentiation 147) Ameliorates Acute Ischemic Stroke in Mice by Reducing Thromboinflammation.

Authors:  Rong Jin; Adam Y Xiao; Rui Chen; D Neil Granger; Guohong Li
Journal:  Stroke       Date:  2017-11-07       Impact factor: 7.914

10.  Phosphoinositide 3-kinase γ affects LPS-induced disturbance of blood-brain barrier via lipid kinase-independent control of cAMP in microglial cells.

Authors:  Adrian Frister; Caroline Schmidt; Nadine Schneble; Michael Brodhun; Falk A Gonnert; Michael Bauer; Emilio Hirsch; Jörg P Müller; Reinhard Wetzker; Reinhard Bauer
Journal:  Neuromolecular Med       Date:  2014-07-18       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.